Symbolbild · KI-generiert
Covalon Technologies Ltd.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Covalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at www.covalon.com.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Covalon Technologies Ltd. | COV | TSXV | 44 Mio. USD |
| Ocumetics Technology Corp. | OTC | TSXV | 43 Mio. USD |
| BioMark Diagnostics Inc. | BUX | CSE | 43 Mio. USD |
| Realbotix Corp. | XBOT | TSXV | 46 Mio. USD |
| Decibel Cannabis Company Inc. | DB | TSXV | 41 Mio. USD |
| Eastwood Bio-Medical Canada Inc. | EBM | TSXV | 48 Mio. USD |
| Arch Biopartners Inc. | ARCH | TSXV | 39 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.